clevidipine has been researched along with vincaleukoblastine in 1 studies
| Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (vincaleukoblastine) | Trials (vincaleukoblastine) | Recent Studies (post-2010) (vincaleukoblastine) |
|---|---|---|---|---|---|
| 127 | 19 | 62 | 69 | 0 | 64 |
| Protein | Taxonomy | clevidipine (IC50) | vincaleukoblastine (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.74 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 4.28 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 8.8 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 4.58 | |
| Proteasome subunit beta type-2 | Homo sapiens (human) | 4.9 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.74 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for clevidipine and vincaleukoblastine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |